journal
https://read.qxmd.com/read/39266711/molecular-and-micro-architectural-mapping-of-gray-matter-alterations-in-psychosis
#21
JOURNAL ARTICLE
Natalia García-San-Martín, Richard A I Bethlehem, Agoston Mihalik, Jakob Seidlitz, Isaac Sebenius, Claudio Alemán-Morillo, Lena Dorfschmidt, Golia Shafiei, Víctor Ortiz-García de la Foz, Kate Merritt, Anthony David, Sarah E Morgan, Miguel Ruiz-Veguilla, Rosa Ayesa-Arriola, Javier Vázquez-Bourgon, Aaron Alexander-Bloch, Bratislav Misic, Edward T Bullmore, John Suckling, Benedicto Crespo-Facorro, Rafael Romero-García
The psychosis spectrum encompasses a heterogeneous range of clinical conditions associated with abnormal brain development. Detecting patterns of atypical neuroanatomical maturation across psychiatric disorders requires an interpretable metric standardized by age-, sex- and site-effect. The molecular and micro-architectural attributes that account for these deviations in brain structure from typical neurodevelopment are still unknown. Here, we aggregate structural magnetic resonance imaging data from 38,696 healthy controls (HC) and 1256 psychosis-related conditions, including first-degree relatives of schizophrenia (SCZ) and schizoaffective disorder (SAD) patients (n = 160), individuals who had psychotic experiences (n = 157), patients who experienced a first episode of psychosis (FEP, n = 352), and individuals with chronic SCZ or SAD (n = 587)...
September 12, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39261672/nicotine-dependence-and-incident-psychiatric-disorders-prospective-evidence-from-us-national-study
#22
JOURNAL ARTICLE
Guillaume Airagnes, Marina Sánchez-Rico, Amélia Deguilhem, Carlos Blanco, Mark Olfson, Charles Ouazana Vedrines, Cédric Lemogne, Frédéric Limosin, Nicolas Hoertel
We examined the prospective associations between nicotine dependence and the likelihood of psychiatric and substance use disorders in the general adult population. Participants came from a nationally representative sample of US adults aged 18 years or older, who were interviewed 3 years apart in the National Epidemiologic Survey on Alcohol and Related Conditions (Wave 1, 2001-2002; Wave 2, 2004-2005). The primary analyses were limited to 32,671 respondents (13,751 male (47.9% weighted); mean age of 45 years (SD = 0...
September 11, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39261671/large-scale-brain-connectivity-changes-following-the-administration-of-lysergic-acid-diethylamide-d-amphetamine-and-3-4-methylenedioxyamphetamine
#23
JOURNAL ARTICLE
Mihai Avram, Lydia Fortea, Lea Wollner, Ricarda Coenen, Alexandra Korda, Helena Rogg, Friederike Holze, Patrick Vizeli, Laura Ley, Joaquim Radua, Felix Müller, Matthias E Liechti, Stefan Borgwardt
Psychedelics have recently attracted significant attention for their potential to mitigate symptoms associated with various psychiatric disorders. However, the precise neurobiological mechanisms responsible for these effects remain incompletely understood. A valuable approach to gaining insights into the specific mechanisms of action involves comparing psychedelics with substances that have partially overlapping neurophysiological effects, i.e., modulating the same neurotransmitter systems. Imaging data were obtained from the clinical trial NCT03019822, which explored the acute effects of lysergic acid diethylamide (LSD), d-amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in 28 healthy volunteers...
September 11, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39256549/whole-brain-turbulent-dynamics-predict-responsiveness-to-pharmacological-treatment-in-major-depressive-disorder
#24
JOURNAL ARTICLE
Anira Escrichs, Yonatan Sanz Perl, Patrick M Fisher, Noelia Martínez-Molina, Elvira G-Guzman, Vibe G Frokjaer, Morten L Kringelbach, Gitte M Knudsen, Gustavo Deco
Depression is a multifactorial clinical syndrome with a low pharmacological treatment response rate. Therefore, identifying predictors of treatment response capable of providing the basis for future developments of individualized therapies is crucial. Here, we applied model-free and model-based measures of whole-brain turbulent dynamics in resting-state functional magnetic resonance imaging (fMRI) in healthy controls and unmedicated depressed patients. After eight weeks of treatment with selective serotonin reuptake inhibitors (SSRIs), patients were classified as responders and non-responders according to the Hamilton Depression Rating Scale 6 (HAMD6)...
September 10, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39245692/peering-into-the-mind-unraveling-schizophrenia-s-secrets-using-models
#25
REVIEW
João V Nani, Alysson R Muotri, Mirian A F Hayashi
Schizophrenia (SCZ) is a complex mental disorder characterized by a range of symptoms, including positive and negative symptoms, as well as cognitive impairments. Despite the extensive research, the underlying neurobiology of SCZ remain elusive. To overcome this challenge, the use of diverse laboratory modeling techniques, encompassing cellular and animal models, and innovative approaches like induced pluripotent stem cell (iPSC)-derived neuronal cultures or brain organoids and genetically engineered animal models, has been crucial...
September 8, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39242950/a-systematic-review-and-meta-analysis-on-the-transcriptomic-signatures-in-alcohol-use-disorder
#26
JOURNAL ARTICLE
Marion M Friske, Eva C Torrico, Maximilian J W Haas, Anna M Borruto, Francesco Giannone, Andreas-Christian Hade, Yun Yu, Lina Gao, Greg T Sutherland, Robert Hitzemann, Mari-Anne Philips, Suzanne S Fei, Wolfgang H Sommer, R Dayne Mayfield, Rainer Spanagel
Currently available clinical treatments on alcohol use disorder (AUD) exhibit limited efficacy and new druggable targets are required. One promising approach to discover new molecular treatment targets involves the transcriptomic profiling of brain regions within the addiction neurocircuitry, utilizing animal models and postmortem brain tissue from deceased patients with AUD. Unfortunately, such studies suffer from large heterogeneity and small sample sizes. To address these limitations, we conducted a cross-species meta-analysis on transcriptome-wide data obtained from brain tissue of patients with AUD and animal models...
September 6, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39237724/impaired-macroautophagy-confers-substantial-risk-for-intellectual-disability-in-children-with-autism-spectrum-disorders
#27
Ahrom Ham, Audrey Yuen Chang, Hongyu Li, Jennifer M Bain, James E Goldman, David Sulzer, Jeremy Veenstra-VanderWeele, Guomei Tang
Autism spectrum disorder (ASD) represents a complex of neurological and developmental disabilities characterized by clinical and genetic heterogeneity. While the causes of ASD are still unknown, many ASD risk factors are found to converge on intracellular quality control mechanisms that are essential for cellular homeostasis, including the autophagy-lysosomal degradation pathway. Studies have reported impaired autophagy in ASD human brain and ASD-like synapse pathology and behaviors in mouse models of brain autophagy deficiency, highlighting an essential role for defective autophagy in ASD pathogenesis...
September 6, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39237723/transcriptomic-pathology-of-neocortical-microcircuit-cell-types-across-psychiatric-disorders
#28
JOURNAL ARTICLE
Keon Arbabi, Dwight F Newton, Hyunjung Oh, Melanie C Davie, David A Lewis, Michael Wainberg, Shreejoy J Tripathy, Etienne Sibille
Psychiatric disorders such as major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SCZ) are characterized by altered cognition and mood, brain functions that depend on information processing by cortical microcircuits. We hypothesized that psychiatric disorders would display cell type-specific transcriptional alterations in neuronal subpopulations that make up cortical microcircuits: excitatory pyramidal (PYR) neurons and vasoactive intestinal peptide- (VIP), somatostatin- (SST), and parvalbumin- (PVALB) expressing inhibitory interneurons...
September 5, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39237722/mir-186-5p-inhibition-restores-synaptic-transmission-and-neuronal-network-activity-in-a-model-of-chronic-stress
#29
JOURNAL ARTICLE
Beatriz Rodrigues, Ricardo A Leitão, Mónica Santos, Alexander Trofimov, Mariline Silva, Ângela S Inácio, Mónica Abreu, Rui J Nobre, Jéssica Costa, Ana Luísa Cardoso, Ira Milosevic, João Peça, Bárbara Oliveiros, Luís Pereira de Almeida, Paulo S Pinheiro, Ana Luísa Carvalho
Chronic stress exerts profound negative effects on cognitive and emotional behaviours and is a major risk factor for the development of neuropsychiatric disorders. However, the molecular links between chronic stress and its deleterious effects on neuronal and synaptic function remain elusive. Here, using a combination of in vitro and in vivo approaches, we demonstrate that the upregulation of miR-186-5p triggered by chronic stress may be a key mediator of such changes, leading to synaptic dysfunction. Our results show that the expression levels of miR-186-5p are increased both in the prefrontal cortex (PFC) of mice exposed to chronic stress and in cortical neurons chronically exposed to dexamethasone...
September 5, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39237721/allosteric-inhibition-of-nmda-receptors-by-low-dose-ketamine
#30
JOURNAL ARTICLE
Jamie A Abbott, Han Wen, Beiying Liu, Sheila S Gupta, Gary J Iacobucci, Wenjun Zheng, Gabriela K Popescu
Ketamine, a general anesthetic, has rapid and sustained antidepressant effects when administered at lower doses. Anesthetic levels of ketamine reduce excitatory transmission by binding deep into the pore of NMDA receptors where it blocks current influx. In contrast, the molecular targets responsible for antidepressant levels of ketamine remain controversial. We used electrophysiology, structure-based mutagenesis, and molecular and kinetic modeling to investigate the effects of ketamine on NMDA receptors across an extended range of concentrations...
September 5, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39237720/obesity-exploring-its-connection-to-brain-function-through-genetic-and-genomic-perspectives
#31
REVIEW
Sadia Saeed, Amélie Bonnefond, Philippe Froguel
Obesity represents an escalating global health burden with profound medical and economic impacts. The conventional perspective on obesity revolves around its classification as a "pure" metabolic disorder, marked by an imbalance between calorie consumption and energy expenditure. Present knowledge, however, recognizes the intricate interaction of rare or frequent genetic factors that favor the development of obesity, together with the emergence of neurodevelopmental and mental abnormalities, phenotypes that are modulated by environmental factors such as lifestyle...
September 5, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39237719/uncovering-convergence-and-divergence-between-autism-and-schizophrenia-using-genomic-tools-and-patients-neurons
#32
JOURNAL ARTICLE
Eva Romanovsky, Ashwani Choudhary, David Peles, Ahmad Abu-Akel, Shani Stern
Autism spectrum disorders (ASDs) are highly heritable and result in abnormal repetitive behaviors and impairment in communication and cognitive skills. Previous studies have focused on the genetic correlation between ASDs and other neuropsychiatric disorders, but an in-depth understanding of the correlation to other disorders is required. We conducted an extensive meta-analysis of common variants identified in ASDs by genome-wide association studies (GWAS) and compared it to the consensus genes and single nucleotide polymorphisms (SNPs) of Schizophrenia (SCZ)...
September 5, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39237718/magnetic-resonance-imaging-of-regional-gray-matter-volume-in-persons-who-died-by-suicide
#33
JOURNAL ARTICLE
E Deininger-Czermak, L Spencer, N Zoelch, A Sankar, D Gascho, R Guggenberger, S Mathieu, M J Thali, H P Blumberg
In vivo neuroimaging research in suicide attempters has shown alterations in frontal system brain regions subserving emotional regulation, motivation, and self-perception; however, data from living individuals is limited in clarifying risk for suicide death. Postmortem neuroimaging provides an approach to study the brain in persons who died by suicide. Here, whole brain voxel-based analyses of magnetic resonance imaging gray matter volume measures were performed comparing persons confirmed by forensic investigation to have died by suicide (n = 24), versus other causes (n = 24), in a univariate model covarying for age and total brain volume; all subjects were scanned within 24 hours after death...
September 5, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39232198/ghsr-blockade-but-not-reduction-of-peripherally-circulating-ghrelin-via-%C3%AE-1-adrenergic-receptor-antagonism-decreases-binge-like-alcohol-drinking-in-mice
#34
JOURNAL ARTICLE
Rani S Richardson, Lindsay A Kryszak, Janaina C M Vendruscolo, George F Koob, Leandro F Vendruscolo, Lorenzo Leggio
Alcohol use disorder (AUD) and binge drinking are highly prevalent public health issues. The stomach-derived peptide ghrelin, and its receptor, the growth hormone secretagogue receptor (GHSR), both of which are expressed in the brain and periphery, are implicated in alcohol-related outcomes. We previously found that systemic and central administration of GHSR antagonists reduced binge-like alcohol drinking, whereas a ghrelin vaccine did not. Thus, we hypothesized that central GHSR drives binge-like alcohol drinking independently of peripheral ghrelin...
September 5, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39232197/gene-environment-correlation-the-role-of-family-environment-in-academic-development
#35
JOURNAL ARTICLE
Quan Zhou, Agnieszka Gidziela, Andrea G Allegrini, Rosa Cheesman, Jasmin Wertz, Jessye Maxwell, Robert Plomin, Kaili Rimfeld, Margherita Malanchini
Academic achievement is partly heritable and highly polygenic. However, genetic effects on academic achievement are not independent of environmental processes. We investigated whether aspects of the family environment mediated genetic effects on academic achievement across development. Our sample included 5151 children who participated in the Twins Early Development Study, as well as their parents and teachers. Data on academic achievement and family environments (parenting, home environments, and geocoded indices of neighbourhood characteristics) were available at ages 7, 9, 12 and 16...
September 4, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39232196/alzheimer-s-disease-biomarkers-and-their-current-use-in-clinical-research-and-practice
#36
REVIEW
Tai R Hunter, Luis E Santos, Fernanda Tovar-Moll, Fernanda G De Felice
While blood-based tests are readily available for various conditions, including cardiovascular diseases, type 2 diabetes, and common cancers, Alzheimer's disease (AD) and other neurodegenerative diseases lack an early blood-based screening test that can be used in primary care. Major efforts have been made towards the investigation of approaches that may lead to minimally invasive, cost-effective, and reliable tests capable of measuring brain pathological status. Here, we review past and current technologies developed to investigate biomarkers of AD, including novel blood-based approaches and the more established cerebrospinal fluid and neuroimaging biomarkers of disease...
September 4, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39227435/human-unique-brain-cell-clusters-are-associated-with-learning-disorders-and-human-episodic-memory-activity
#37
JOURNAL ARTICLE
Junjie Ma, Ruicheng Qi, Jing Wang, Stefano Berto, Guang-Zhong Wang
The advanced evolution of the human cerebral cortex forms the basis for our high-level cognitive functions. Through a comparative analysis of single-nucleus transcriptome data from the human neocortex and that of chimpanzees, macaques, and marmosets, we discovered 20 subgroups of cell types unique to the human brain, which include 11 types of excitatory neurons. Many of these human-unique cell clusters exhibit significant overexpression of genes regulated by human-specific enhancers. Notably, these specific cell clusters also express genes associated with disease risk, particularly those related to brain dysfunctions like learning disorders...
September 3, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39227434/rewarding-properties-of-l-dopa-in-experimental-parkinsonism-are-mediated-by-sensitized-dopamine-d1-receptors-in-the-dorsal-striatum
#38
JOURNAL ARTICLE
Carina Plewnia, Débora Masini, Gilberto Fisone
Treatment of Parkinson's disease (PD) is based on the use of dopaminergic drugs, such as L-Dopa and dopamine receptor agonists. These substances counteract motor symptoms, but their administration is accompanied by motor and non-motor complications. Among these latter conditions a neurobehavioral disorder similar to drug abuse, known as dopamine dysregulation syndrome (DDS), is attracting increasing interest because of its profound negative impact on the patients' quality of life. Here we replicate DDS in a PD mouse model based on a bilateral injection of 6-hydroxydopamine (6-OHDA) into the dorsal striatum...
September 3, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39227433/dna-methylation-and-histone-modifications-associated-with-antipsychotic-treatment-a-systematic-review
#39
JOURNAL ARTICLE
Diogo Marques, Nazanin Vaziri, Steven C Greenway, Chad Bousman
Antipsychotic medications are essential when treating schizophrenia spectrum and other psychotic disorders, but the efficacy and tolerability of these medications vary from person to person. This interindividual variation is likely mediated, at least in part, by epigenomic processes that have yet to be fully elucidated. Herein, we systematically identified and evaluated 65 studies that examine the influence of antipsychotic drugs on epigenomic changes, including global methylation (9 studies), genome-wide methylation (22 studies), candidate gene methylation (16 studies), and histone modification (18 studies)...
September 3, 2024: Molecular Psychiatry
https://read.qxmd.com/read/39227432/valproic-acid-induced-teratogenicity-is-driven-by-senescence-and-prevented-by-rapamycin-in-human-spinal-cord-and-animal-models
#40
JOURNAL ARTICLE
Giovanni Pietrogrande, Mohammed R Shaker, Sarah J Stednitz, Farhad Soheilmoghaddam, Julio Aguado, Sean D Morrison, Samuel Zambrano, Tahmina Tabassum, Ibrahim Javed, Justin Cooper-White, Thomas P Davis, Terence J O'Brien, Ethan K Scott, Ernst J Wolvetang
Valproic acid (VPA) is an effective and widely used anti-seizure medication but is teratogenic when used during pregnancy, affecting brain and spinal cord development for reasons that remain largely unclear. Here we designed a genetic recombinase-based SOX10 reporter system in human pluripotent stem cells that enables tracking and lineage tracing of Neural Crest cells (NCCs) in a human organoid model of the developing neural tube. We found that VPA induces extensive cellular senescence and promotes mesenchymal differentiation of human NCCs...
September 3, 2024: Molecular Psychiatry
journal
journal
32543
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.